Ameriprise’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $111K | Buy |
11,803
+1,443
| +14% | +$13.5K | ﹤0.01% | 3844 |
|
2025
Q1 | $73.7K | Sell |
10,360
-21,349
| -67% | -$152K | ﹤0.01% | 3880 |
|
2024
Q4 | $370K | Buy |
31,709
+529
| +2% | +$6.17K | ﹤0.01% | 3616 |
|
2024
Q3 | $641K | Sell |
31,180
-4,791
| -13% | -$98.5K | ﹤0.01% | 3388 |
|
2024
Q2 | $804K | Buy |
35,971
+3,851
| +12% | +$86.1K | ﹤0.01% | 3242 |
|
2024
Q1 | $884K | Sell |
32,120
-277,092
| -90% | -$7.62M | ﹤0.01% | 3218 |
|
2023
Q4 | $9.43M | Buy |
309,212
+275,857
| +827% | +$8.41M | ﹤0.01% | 1831 |
|
2023
Q3 | $1.05M | Buy |
33,355
+16,602
| +99% | +$523K | ﹤0.01% | 3119 |
|
2023
Q2 | $683K | Buy |
16,753
+266
| +2% | +$10.8K | ﹤0.01% | 3320 |
|
2023
Q1 | $614K | Sell |
16,487
-394,335
| -96% | -$14.7M | ﹤0.01% | 3343 |
|
2022
Q4 | $14.3M | Sell |
410,822
-24,154
| -6% | -$842K | ﹤0.01% | 1446 |
|
2022
Q3 | $24.3M | Buy |
434,976
+20,819
| +5% | +$1.16M | 0.01% | 1061 |
|
2022
Q2 | $21.4M | Sell |
414,157
-18,003
| -4% | -$932K | 0.01% | 1167 |
|
2022
Q1 | $31.4M | Sell |
432,160
-5,330
| -1% | -$387K | 0.01% | 1032 |
|
2021
Q4 | $51.7M | Buy |
437,490
+713
| +0.2% | +$84.3K | 0.01% | 827 |
|
2021
Q3 | $58.6M | Buy |
436,777
+219,321
| +101% | +$29.4M | 0.02% | 694 |
|
2021
Q2 | $35.2M | Buy |
217,456
+202,813
| +1,385% | +$32.8M | 0.01% | 966 |
|
2021
Q1 | $1.22M | Buy |
14,643
+6,490
| +80% | +$542K | ﹤0.01% | 3062 |
|
2020
Q4 | $312K | Buy |
+8,153
| New | +$312K | ﹤0.01% | 3489 |
|
2019
Q4 | – | Sell |
-11,281
| Closed | -$150K | – | 3738 |
|
2019
Q3 | $150K | Sell |
11,281
-23,570
| -68% | -$313K | ﹤0.01% | 3594 |
|
2019
Q2 | $570K | Buy |
34,851
+23,057
| +195% | +$377K | ﹤0.01% | 3275 |
|
2019
Q1 | $202K | Buy |
+11,794
| New | +$202K | ﹤0.01% | 3537 |
|
2018
Q4 | – | Sell |
-94,381
| Closed | -$2.7M | – | 3722 |
|
2018
Q3 | $2.7M | Sell |
94,381
-9,640
| -9% | -$276K | ﹤0.01% | 2688 |
|
2018
Q2 | $2.76M | Buy |
+104,021
| New | +$2.76M | ﹤0.01% | 2586 |
|